Werewolf Therapeutics reported a net margin of 33.14% for the quarter ended Jun 2026. These financial ratios cover 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||
| EBT Margin | -358.61% | -240.36% | -164.77% | -243.64% | -62.78% | -140.41% | -799.27% | -2,182.21% | -1,601.84% | -135,373.33% | 33.14% | |||||||||||
| EBIT Margin | -360.95% | -252.29% | -180.96% | -273.81% | -75.08% | -156.88% | -863.56% | -2,312.94% | -1,658.79% | -135,653.33% | 34.09% | |||||||||||
| EBITDA Margin | -360.95% | -252.29% | -180.96% | -273.81% | -75.08% | -156.88% | -863.56% | -2,312.94% | -1,658.79% | -135,653.33% | 34.09% | |||||||||||
| Operating Margin | -360.95% | -252.29% | -180.96% | -273.81% | -75.08% | -156.88% | -863.56% | -2,312.94% | -1,658.79% | -135,653.33% | 34.09% | |||||||||||
| Net Margin | -351.83% | -240.30% | -163.81% | -243.64% | -62.78% | -140.41% | -799.27% | -2,182.21% | -1,601.84% | -135,373.33% | 33.14% | |||||||||||
| FCF Margin | -15.24% | -315.57% | -170.09% | -225.49% | -137.40% | -125.98% | -318.65% | -2,076.55% | -1,241.82% | -95,833.33% | 31.57% | |||||||||||
| Efficiency | ||||||||||||||||||||||
| Assets AverageAssets Avg. | 184.40M | 178.81M | 171.94M | 169.98M | 173.88M | 166.33M | 177.66M | 190.15M | 180.81M | 175.61M | 176.22M | 165.65M | 146.87M | 133.48M | 117.08M | 99.90M | 86.10M | 74.51M | 63.71M | 41.09M | ||
| Invested CapitalInvested Cap. | 122.34M | 160.14M | 157.74M | 151.67M | 150.70M | 157.00M | 129.18M | 115.00M | 99.48M | 83.89M | 68.57M | 57.27M | 53.04M | 41.03M | 16.29M | |||||||
| Asset Utilization RatioAsset Util. | 0.02 | 0.05 | 0.10 | 0.12 | 0.13 | 0.14 | 0.11 | 0.09 | 0.06 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.51 | |||||||
| Leverage & Solvency | ||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -71.06 | -6.35 | -9.23 | -12.83 | -17.11 | -16.60 | -13.77 | -16.06 | -14.24 | -13.48 | -11.73 | -6.88 | -9.70 | 15.07 | ||||||||
| Debt Ratio | 0.20 | 0.21 | 0.22 | 0.22 | 0.22 | 0.16 | 0.18 | 0.21 | 0.25 | 0.29 | 0.35 | 0.41 | 0.50 | |||||||||
| Times Interest Earned | -71.06 | -6.35 | -9.23 | -12.83 | -17.11 | -16.60 | -13.77 | -16.06 | -14.24 | -13.48 | -11.73 | -6.88 | -9.70 | 15.07 | ||||||||
| Valuation | ||||||||||||||||||||||
| Price to EarningsP/E | -33.95 | -12.30 | -7.86 | -7.92 | -11.56 | -5.40 | -8.44 | -21.43 | -9.22 | -12.58 | -17.32 | -5.82 | -5.53 | -3.27 | -2.38 | -2.75 | -5.69 | -2.99 | -2.84 | 2.51 | ||
| Price to SalesP/S | 27.88 | 27.78 | 8.85 | 20.56 | 13.45 | 12.94 | 100.57 | 377.99 | 93.29 | 0.00M | 0.83 | |||||||||||
| Price to BookP/B | 2.76 | 1.44 | 0.87 | 0.89 | 1.05 | 0.53 | 0.76 | 0.92 | 0.68 | 1.36 | 2.39 | 1.03 | 1.04 | 0.90 | 0.76 | 1.19 | 3.14 | 1.23 | 3.31 | 1.07 | ||
| Enterprise Value | 296.64M | 62.27M | -23.06M | -30.05M | -2.39M | -64.88M | -56.09M | -28.74M | -53.75M | 16.61M | 141.28M | -28.67M | -30.14M | -44.65M | -48.56M | -28.18M | 27.42M | -26.43M | -6.16M | -4.50M | ||
| EV to EBIT | -21.50 | -3.48 | 1.50 | 2.01 | 0.19 | 4.92 | 4.59 | 4.74 | 5.81 | -1.28 | -8.23 | 1.51 | 1.76 | 2.19 | 2.70 | 1.61 | -1.74 | 2.81 | 0.46 | -0.63 | ||
| EV to EBITDA | -21.50 | -3.48 | 1.50 | 2.01 | 0.19 | 4.92 | 4.59 | 4.74 | 5.81 | -1.28 | -8.23 | 1.51 | 1.76 | 2.19 | 2.70 | 1.61 | -1.74 | 2.81 | 0.46 | -0.63 | ||
| Market Capitalization | 467.08M | 219.80M | 120.65M | 115.66M | 138.06M | 64.44M | 91.78M | 108.71M | 76.31M | 150.95M | 280.47M | 106.63M | 92.69M | 66.34M | 43.48M | 49.42M | 93.13M | 30.62M | 40.34M | 17.50M | ||
| Price to FCFP/FCF | -37.31 | -16.78 | -7.78 | -183.00 | -8.80 | -5.20 | -9.12 | -9.79 | -10.27 | -31.56 | -18.20 | -7.51 | -7.44 | -4.62 | -2.29 | -3.26 | -6.14 | -2.78 | -3.81 | 2.64 | ||
| EV to FCF | -23.70 | -4.75 | 1.49 | 47.56 | 0.15 | 5.24 | 5.57 | 2.59 | 7.24 | -3.47 | -9.17 | 2.02 | 2.42 | 3.11 | 2.56 | 1.86 | -1.81 | 2.40 | 0.58 | -0.68 | ||
| EV to CFO | -23.89 | -4.91 | 1.65 | 99.19 | 0.17 | 5.47 | 5.67 | 2.63 | 7.46 | -3.62 | -9.24 | 2.02 | 2.42 | 3.13 | 2.56 | 1.86 | -1.81 | 2.40 | 0.58 | -0.68 | ||
| Return Ratios | ||||||||||||||||||||||
| Return on Sales [ROS]ROS | -360.95% | -252.29% | -180.96% | -273.81% | -75.08% | -156.88% | -863.56% | -2,312.94% | -1,658.79% | -1,955.35% | -135,653.33% | -6,426.86% | -486,700.00% | -477,380.00% | 34.09% | |||||||
| Return on Capital Employed [ROCE]ROCE | -22.42% | -30.00% | -36.05% | -44.42% | -41.60% | -39.38% | -33.93% | -25.13% | -24.48% | -25.92% | -29.32% | -37.83% | -49.26% | -62.21% | -70.60% | -86.16% | -104.55% | -158.16% | -222.14% | -94.08% | ||
| Return on Assets [ROA]ROA | -21.41% | -27.96% | -33.67% | -36.39% | -34.55% | -32.55% | -27.97% | -20.98% | -20.04% | -20.63% | -23.57% | -33.07% | -43.08% | -53.62% | -62.90% | -73.40% | -84.70% | -84.34% | -92.28% | -82.36% |